Works matching IS 03407004 AND DT 2000 AND VI 49 AND IP 8
Results: 7
Induction of human cytotoxic T lymphocytes that preferentially recognise tumour cells bearing a conformational p53 mutant.
- Published in:
- Cancer Immunology, Immunotherapy, 2000, v. 49, n. 8, p. 417, doi. 10.1007/s002620000137
- By:
- Publication type:
- Article
CD40 activation enhances the magnitude of cellular immune responses against p53 but not the avidity of the effectors.
- Published in:
- Cancer Immunology, Immunotherapy, 2000, v. 49, n. 8, p. 410, doi. 10.1007/s002620000135
- By:
- Publication type:
- Article
Inhibition of interleukin-10 (IL-10) production from MOPC 315 tumor cells by IL-10 antisense oligodeoxynucleotides enhances cell-mediated immune responses.
- Published in:
- Cancer Immunology, Immunotherapy, 2000, v. 49, n. 8, p. 433, doi. 10.1007/s002620000123
- By:
- Publication type:
- Article
Synergy between interleukin-2 and prothymosin α for the increased generation of cytotoxic T lymphocytes against autologous human carcinomas.
- Published in:
- Cancer Immunology, Immunotherapy, 2000, v. 49, n. 8, p. 449, doi. 10.1007/s002620000132
- By:
- Publication type:
- Article
A bispecific single-chain antibody directed against EpCAM/CD3 in combination with the cytokines interferon α and interleukin-2 efficiently retargets T and CD3<sup>+</sup>CD56<sup>+</sup> natural-killer-like T lymphocytes to EpCAM-expressing tumor cells
- Published in:
- Cancer Immunology, Immunotherapy, 2000, v. 49, n. 8, p. 441, doi. 10.1007/s002620000130
- By:
- Publication type:
- Article
Enhancement of the photodynamic antitumor effect by streptococcal preparation OK-432 in the mouse carcinoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2000, v. 49, n. 8, p. 401, doi. 10.1007/s002620000134
- By:
- Publication type:
- Article
Comparative delineation of T cell clonotypes in coexisting syngeneic B16 melanoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2000, v. 49, n. 8, p. 426, doi. 10.1007/s002620000136
- By:
- Publication type:
- Article